Skip to main content

Research Repository

Advanced Search

P25. Tolerance and diagnostic accuracy of myocardial scintigraphy with adenosine infusion, 6 min (standard) versus 3 min (abbreviated) protocol

Gopinath, G; Buscombe, JR; Naojee, S; Szczepura, K; Hilson, AJW

Authors

G Gopinath

JR Buscombe

S Naojee

AJW Hilson



Abstract

Myocardial perfusion scintigraphy with adenosine is an effective and safe method for diagnosing coronary artery disease (CAD). Various reports suggest that a 3 min stress regime is as efficacious as a 6 min regime. The aim of the study was to study the tolerance and efficacy of these two regimes. Two hundred and eighty-one patients (100, 6 min; 181, 3 min) had adenosine stressed myocardial scintigraphy. Blood pressures, heart rate and ECG were recorded at baseline and during the test. Any symptoms (flushing, headache, chest pain, dyspnoea and neck pain) were also recorded throughout and for 5 min after the adenosine infusion. 117/281 patients (41.6%) reported side effects including flushing (33% in 3 min vs 45% 6 min, P<0.05), headache (12.7% vs 9%, not significant (NS)), chest pain (7% vs 10%, NS), dyspnoea (7.7% vs 13%, NS), and neck pain (4.9% vs 7%). Significant ECG changes occurred in (9.3% vs 27%, P<0.001). The two regimes protocol had a similar positivity rate (70% 3 min vs 73% 6 min, NS) for the detection of CAD. The patients tolerated the 3 min regime better with the most common side effect being flushing. All this is achieved without loss of efficacy of the test. The 3 min regime also uses £25.00 less adenosine per patient.

Citation

Gopinath, G., Buscombe, J., Naojee, S., Szczepura, K., & Hilson, A. (2003). P25. Tolerance and diagnostic accuracy of myocardial scintigraphy with adenosine infusion, 6 min (standard) versus 3 min (abbreviated) protocol. Nuclear Medicine Communications, 24(4), 476. https://doi.org/10.1097/00006231-200304000-00114

Journal Article Type Conference Paper
Conference Name 31st annual meeting of the British Nuclear Medicine Society
Conference Location Manchester, United Kingdom
Start Date Apr 29, 2003
End Date May 1, 2003
Publication Date Apr 1, 2003
Deposit Date Feb 26, 2021
Journal Nuclear Medicine Communications
Print ISSN 0143-3636
Electronic ISSN 1473-5628
Publisher Lippincott, Williams & Wilkins
Volume 24
Issue 4
Pages 476
DOI https://doi.org/10.1097/00006231-200304000-00114
Publisher URL https://doi.org/10.1097/00006231-200304000-00114
Related Public URLs http://www.nuclearmedicinecomm.com/
Additional Information Event Type : Conference